Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders
source: unsplash.com

Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders

According to a story from World Pharma Today, Andelyn Biosciences, Inc., which is a gene therapy Contract Development and Manufacturing Organization (CDMO), has recently struck a partnership with Odylia Therapeutics,…

Continue Reading Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders

Phase 3 Data Highlights the Benefits of Nivolumab for Urothelial Carcinoma

In August 2021, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) for the adjuvant treatment of a rare form of cancer called urothelial carcinoma. More particularly, the drug…

Continue Reading Phase 3 Data Highlights the Benefits of Nivolumab for Urothelial Carcinoma
Cristian Shares His Wilms’ Tumor Story
https://pixabay.com/en/american-football-football-sports-1666276/

Cristian Shares His Wilms’ Tumor Story

If there’s one way that 11-year-old Cristian Muñoz would describe himself, it would be an athlete. Cristian has always been drawn to playing sports: the rigor, the competition, the connection…

Continue Reading Cristian Shares His Wilms’ Tumor Story